Search results
Found 7347 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
MSD Teaching Excellence Awards 2023
7 November 2023
The 2023 MSD Teaching Excellence Awards have been celebrated in a ceremony at Oxford Town Hall, on Tuesday 31st October. The ceremony was hosted by the Head of Division, Professor Gavin Screaton, the Associate Head of Division (Education), Professor Helen Christian, and the Head of Education Policy and Planning, Jane Dale.
Prof Anna Schuh launches first private specialised haematology clinic and laboratory in sub-Saharan Africa
6 November 2023
SerenOx Africa aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility will also aim to provide early cancer detection for high-risk patients.
CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
6 November 2023
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, while also looking to improve manufacturing speed and scale-up of ChAdOx technology. Learnings could be leveraged to inform vaccine design for related viruses from the Arenavirus family, giving the world a head start in rapidly responding to future outbreaks in as little as 100 days. First project to be initiated under CEPI and University of Oxford’s strategic partnership to accelerate global pandemic preparedness efforts.
Celebrating 5 Years of the BioEscalator
1 November 2023
The BioEscalator recently marked its 5th anniversary with a celebration that showcased the impressive journeys of some of its current and graduated biotech companies.
RECOVERY trial expands to investigate treatments for influenza
31 October 2023
The RECOVERY trial, which discovered four effective treatments for COVID-19, has expanded to investigate treatments for influenza (flu).
Oxford launches new vaccine trial to enhance design of flu & COVID-19 vaccines
26 October 2023
This study will test the responses of cells in lymph nodes before and after immunisation with flu and COVID-19 vaccines and compare reactions in older and younger adults
First digital atlas of human fetal brain development published
25 October 2023
The first digital atlas showing how the human brain develops in the womb has been published by a global research team led by the University of Oxford.
Estimating hospital-acquired SARS-CoV-2 infections in England
23 October 2023
An estimated 95,000–167,000 inpatients at English National Health Service (NHS) hospitals caught SARS-CoV-2 while in hospital during England’s ‘second wave’ of COVID-19, between June 2020 and March 2021, reports a study in Nature. The findings reveal the scale of hospital transmissions and highlight contributing factors, such as a limited number of single rooms.
New AI tool could help predict viral outbreaks
19 October 2023
As the COVID-19 pandemic demonstrated, viruses can quickly evolve new ways of evading our immune systems, undermining our efforts to control outbreaks. But a new artificial intelligence (AI) tool developed by researchers at the University of Oxford and Harvard Medical School could help predict new viral variants before they emerge. The findings have been published in the journal Nature.
New translational unit launched to further critical research into multiple myeloma
19 October 2023
The Oxford Translational Myeloma Centre (OTMC) will be a collective force of research, outreach and patient care that will transform treatment opportunities for multiple myeloma cancer patients.
Radcliffe Science Library Reopened!
17 October 2023
Back in February 2020 the Radcliffe Science Library (RSL) team packed up our boxes, moved our books to the VHL and closed the doors on the RSL. This was to allow a thorough refurbishment of the building. Now more than three years later the RSL has reopened to the staff and the students of the University of Oxford.
Professor Eileen Parkes appointed to lead Oxford’s Experimental Cancer Medicine Centre
17 October 2023
Eileen Parkes, Associate Professor in Innate Tumour Immunology in the Department of Oncology, will lead the expansion of the Oxford’s Experimental Cancer Medicine Centre (ECMC) programmes in early drug development and biomarker research.
Scholarship programme for the innovators of the future launched
13 October 2023
The Ellison Scholars programme, announced by the Ellison Institute of Technology (EIT), will find and fund students and train them to become leaders with the skills to invent, improve, and manage the next generation of technology, to help solve some of humanity’s most challenging and enduring problems.
Tackling persistent inequities underlying maternal mortality
12 October 2023
The Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK) collaboration, co-led by Nuffield Department of Population Health’s National Perinatal Epidemiology Unit, has published the full Saving Lives, Improving Mothers’ Care report on women who died during, or up to a year after, pregnancy between 2019 and 2021.
Palestinian medical students visit Oxford for MedEd summer school
11 October 2023
In July and August, twenty medical students from the Arab American University of Palestine (AAUP), based in Jenin, visited Oxford for two weeks to learn clinical skills and observe OUH clinicians.
Tackling mental illness by supporting industry to develop new drugs
11 October 2023
An academic/industry partnership, based at the NIHR Oxford Health Biomedical Research Centre, is helping companies use experimental medicine approaches to speed up development of new drugs to treat psychiatric disorders.
The Big Shot. Oxford, Africa and the R21 malaria vaccine
11 October 2023
What we desperately need are new tools to improve malaria control, and this is the first vaccine that can be deployed at scale, that will be affordable, and can be used widely in Africa on a scale of hundreds of millions of doses each year.
Oxford to lead global collaboration to research and develop next-generation COVID-19 and flu vaccines
11 October 2023
Project headed by Oxford University’s Professor Teresa Lambe OBE (Calleva Head of Vaccinology and Immunology, Department of Paediatrics) and co-developer of the Oxford/AstraZeneca COVID-19 vaccine and Paul Klenerman (Sidney Truelove Professor, Nuffield Department of Medicine)
‘We could eradicate malaria by 2040’ says expert after revolutionary vaccine is approved by WHO
11 October 2023
The World Health Organization has approved a new vaccine that scientists argue will be a game-changer in the fight against malaria, which kills half a million people in Africa every year. Trials have shown that the R21/Matrix vaccine, developed by Oxford University together with the Serum Institute of India, reduces malaria by up to 75%. It can be manufactured cheaply and on a mass scale. The Conversation Weekly spoke to chief investigator Adrian Hill, who is also director of the Jenner Institute at the University of Oxford, about this revolutionary vaccine. Below are edited excerpts from the podcast.